Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu(University of Turku), Maija Hollmén(University of Turku)
Cited by 53